daily subchronic administration of pf significantly reduced anxiety-like behaviour in rats (p < 0·05) and alleviated psychological distress in volunteers, as measured particularly by the hscl-90 scale (global severity index, p < 0·05; somatisation, p < 0·05; depression, p < 0·05; and anger-hostility, p < 0·05), the hads (hads global score, p < 0·05; and hads-anxiety, p < 0·06), and by the ccl (problem solving, p < 0·05) and the ufc level (p < 0·05).